Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached $119 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback